Finding Providers

We found 4 mohs skin cancer surgeons who accept Humana Catastrophic near De Pere, WI.

Showing 1-4 of 4
Kevan Gerard Lewis MD, FAAD
Specializes in MOHS-Micrographic Surgery, Dermatopathology
2221 S Webster Avenue; Suite 241
Green Bay, WI
(920) 965-0345; (920) 569-6549

Dr. Kevan Lewis practices dermatopathology and MOHS-micrographic surgery. Areas of expertise for Dr. Lewis include skin issues. Patient ratings for Dr. Lewis average 4.0 stars out of 5. He is an in-network provider for several insurance carriers, including Humana HMO, Humana Bronze, and Humana Catastrophic. After attending the University of California, Los Angeles (UCLA), David Geffen School of Medicine, he completed his residency training at Rhode Island Hospital. He is conversant in Spanish. Dr. Lewis's professional affiliations include the University of Colorado Hospital (UCH) and ThedaCare.

Read more

Clinical interests: Medical Dermatology

Dr. Lisa Lynne Butenhoff Campbell MD, FAAD
Specializes in MOHS-Micrographic Surgery
1400 Scheuring Road
De Pere, WI
(920) 968-1790; (920) 964-0229

Dr. Lisa Campbell is a specialist in MOHS-micrographic surgery. In her practice, Dr. Campbell focuses on skin cancer. The average patient rating for Dr. Campbell is 5.0 stars out of 5. She accepts Humana HMO, Humana Bronze, and Humana Catastrophic, in addition to other insurance carriers. After attending the University of Wisconsin School of Medicine and Public Health for medical school, she completed her residency training at Geisinger Medical Center and Gundersen Lutheran. She is affiliated with Aurora BayCare Medical Center.

Read more

Clinical interests: Skin Cancer

Dr. Kurt Walter Grelck DO
Specializes in Internal Medicine (Adult Medicine), MOHS-Micrographic Surgery, Pediatric Dermatology
1400 Scheuring Road
De Pere, WI
(920) 849-2100; (920) 725-4100

Dr. Kurt Grelck is a pediatric dermatology and MOHS-micrographic surgery specialist in Chilton, WI, Grafton, WI, and Kenosha, WI. Clinical interests for Dr. Grelck include phototherapy (light therapy), contact dermatitis, and hair problems. Dr. Grelck is affiliated with ThedaCare. He takes Humana HMO, Humana Bronze, Humana Catastrophic, and more. He graduated from Midwestern University, Chicago College of Osteopathic Medicine.

Read more

Clinical interests: Cosmetic Dermatology, Birthmarks, Contact Dermatitis, Cutaneous T-Cell Lymphoma, Hair Disorders, ... (Read more)

David Eugene Bertler MD, FAAD
Specializes in MOHS-Micrographic Surgery
1400 Scheuring Road
De Pere, WI
(920) 968-1790; (920) 964-1790

Dr. David Bertler works as a mohs skin cancer surgeon. Areas of particular interest for Dr. Bertler include contact dermatitis, psoriasis, and skin cancer. Dr. Bertler's hospital/clinic affiliations include Aurora Medical Center in Manitowoc County and Aurora BayCare Medical Center. He accepts several insurance carriers, including Humana HMO, Humana Bronze, and Humana Catastrophic. Before performing his residency at Fitzsimons Army Medical Center and a hospital affiliated with the University of Colorado Denver, Dr. Bertler attended Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine.

Read more

Clinical interests: Contact Dermatitis, Medical Dermatology, Psoriasis, Skin Cancer


Conditions / Treatments


Medicare Patient Ethnicity


Foreign Language

Online Communication

Patient Demographic

Practice Affiliation



Medical School


Years Since Graduation

What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.